Answers are grounded in this paper and cite their sources.
Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory tract disease, underscoring the need for safe, scalable platforms to evaluate neutralizing antibodies, and entry-targeting antivirals. Here, we established and characterized a vesicular stomatitis virus (VSV)-based pseudovirus neutralization assay for RSV that uses fusion (F) proteins from RSV A and RSV B strains as functional entry glycoproteins. Key assay parameters were systematically evaluated, including target cell type, F-expression plasmid input, packaging multiplicity of infection, pseudovirus inoculum, detection time point, and cell seeding density. Western blotting confirmed F expression and incorporation into pseudovirus particles, and a GFP reporter-based syncytium assay verified fusion activity. Under the selected assay conditions, the assay showed strong signal linearity, low background, and reproducible reporter readouts in HEK293T cells at 24 h post-infection. Neutralization by monoclonal antibodies targeting six major antigenic sites on RSV F (sites Ø and I-V) supported the functional preservation and accessibility of multiple neutralization-relevant epitopes on the pseudovirus surface. RSV-specific fusion inhibitors selectively blocked both pseudovirus entry and F-mediated cell-cell fusion in a dose-dependent manner, whereas SARS-CoV-2 entry inhibitors had no effect, consistent with the expected virus-specific inhibition profiles. Importantly, pseudovirus neutralization titers showed positive correlations with live-virus neutralization results in both human and mouse sera. Together, these findings establish the VSV-RSV pseudovirus neutralization assay as a robust and scalable platform for measuring F-directed neutralizing activity and for supporting vaccine evaluation, serological surveillance, monoclonal antibody characterization, and antiviral discovery.IMPORTANCERespiratory syncytial virus (RSV) causes substantial disease in infants, older adults, and immunocompromised individuals, underscoring the need for robust assays to evaluate vaccines, antibodies, and antivirals. Authentic-virus assays remain essential because they measure neutralization in the context of intact RSV, but the involvement of multiple viral components can complicate attribution of neutralization differences specifically to F. The vesicular stomatitis virus-based pseudovirus system developed here uses F as the sole RSV envelope glycoprotein and restricts infection to a single reporter-expressing round, enabling controlled comparisons of F variants, F-directed antibodies, and entry inhibitors. Its positive correlation with authentic-virus neutralization further supports its utility as a complementary platform for mechanistic and comparative studies of RSV F-directed entry and neutralization.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: